ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

AI and Health Equity in California

June 25, 2024

Author(s):

Rachel Radwan

Explore key takeaways from the California Health Care Foundation discussion on artificial intelligence and its effect on health care delivery in California.

AI and Health Equity in California

This April, the California Health Care Foundation (CHCF) hosted a discussion on artificial intelligence (AI) and its effect on health care delivery in California. CHCF is an independent, nonprofit philanthropy working to improve the state's health care system and provide individuals with the care they need; especially those from communities that experience significant barriers to care.

The session’s moderator, Kara Carter, senior vice president of Strategy and Programs at CHCF, called out the potential of AI to transform health care in a positive way. According to Carter, AI can help doctors sift through mountains of data to diagnose diseases faster and more accurately, while making real-time updates to electronic medical records. This will allow physicians to reduce what Carter refers to as “pajama time” (time spent charting and reviewing patient notes early in the morning or late at night), while reducing burnout, and ultimately increasing job satisfaction. “Providers will be able to prioritize patient interactions even more,” Carter said.

Carter also emphasized the real risks AI poses, including concerns about data privacy, irresponsible oversight, inequitable access to the benefits it can bring, and algorithms that perpetuate bias and health inequity. Thus, Carter argues it is essential policy leaders ensure that AI is responsibly deployed to the benefit of the public. “The goal of AI should be to support and augment the workforce instead of replacing it, and to build trust instead of suspicion in the health care system,” she said.

AI Opportunities in the Safety Net

Following her address, Carter welcomed keynote speaker, Mark Ghaly, MD, MPH, secretary, California Health and Human Services. Dr. Ghaly’s discussion focused on the impact of AI on California’s safety net: a grouping of programs and providers across the state that specialize in coverage and care for patients with low incomes, no insurance, and/or special medical needs.

According to Dr. Ghaly, adopting new technologies is typically delayed for providers within the safety net when compared to larger organizations with more resources. Even today, not all providers within the safety net are using an electronic health record (EHR). Thus, Dr. Ghaly emphasized that this trend must not be replicated with the adoption of AI.

Dr. Ghaly believes it is important to balance both the fears and the optimism of emerging technologies. “One of the areas that we have significant fear around,” Dr. Ghaly said, “is whether the government can actually create a regulatory framework that supports and secures equity, quality, and access in all the ways we can imagine.” These are valid concerns, that invite and enlist policymakers to pave the way for responsible and equitable use of AI across all communities.

Dr. Ghaly also provided a useful case for AI in the form of a community health worker. Daily, they may use AI to capture notes during visits with clients, to make better sense of the data collected during those visits, or to develop culturally competent and linguistically appropriate follow-up. “[It] requires us to look at tools like AI and other technologies not with fear, but with confidence that together, we can imagine ways to use it more effectively,” he noted.

To prevent the misuse of AI, Dr. Ghaly spoke to the need for core values that guide the deployment of AI tools, including addressing health inequities, promoting accountability and transparency, generating demonstrated value, empowering human capacity, strengthening community, cultivating innovation, and improving accessibility. In response to health care workers’ worry that AI will replace their roles, Dr. Ghaly called on policymakers and leaders to guide those conversations and be sensitive to the workforce impacts of AI. “This technology shouldn’t be a threat to jobs, but an aide for health care workers to free up their time for the more fulfilling, patient-facing aspects of their roles,” he said.

Dr. Ghaly closed by reiterating the importance of collaboration as the health care continuum works to leverage emerging technologies to build a better future and improve outcomes for all patients.

Framing AI

Next, panelists Susan Ehrlich, MD, MPP, CEO of the Priscilla Chan and Mark Zuckerberg San Francisco General Hospital and Trauma Center, and professor of medicine, UCSF; Carolina Reyes, MD, associate clinical professor, Maternal Fetal Medicine, School of Medicine, UC Davis Health, chair of the board of directors of the California Health Care Foundation, and board member of Common Spirit Health; and David Lubarsky, MD, MBA, FASA, vice chancellor of Human Health Sciences and chief executive officer, UC Davis Health, were invited to speak about their experiences using AI in their respective programs.

Dr. Lubarsky discussed trust as a significant barrier to the practical implementation of AI. “The speed of trust determines the speed of change,” he said. “You can’t get anywhere unless people actually believe AI is a good thing.” He also expressed that this resistance is often healthy and necessary, especially when providers demand proof that new technology will not negatively affect patient safety and care.

Dr. Lubarsky then reframed AI as “augmented intelligence” rather than artificial intelligence. “It is not artificial,” he explained. “It simply processes large amounts of data more quickly and accurately than a human can do on their own.” He echoed Dr. Ghaly’s sentiment that AI should be viewed as an assistant—not a replacement—for health care workers, capable of drawing their attention to what needs to be done.

Equity Concerns

Carter then posed the question of how the health care community can ensure these benefits of AI reach all communities in California, not just the wealthy ones. Dr. Ehrlich acknowledged that AI requires vast resources in the form of expertise, time, and money. She also expressed that her hospital, Zuckerberg San Francisco General, has witnessed the effects of the disparity in resources firsthand. “We’re watching our colleagues at UCSF move far ahead of us in their ability to take advantage of these technologies—AI, machine learning—just because they have more resources than we do,” Dr. Ehrlich said.

Dr. Reyes added that in the discussion of AI implementation, it is crucial for providers to keep their guiding principles at the forefront. If a new tool or method doesn’t allow them to treat patients with dignity and give them the best care possible, it should not be used. She was also hopeful that the introduction of AI will allow patient interactions to be much more focused on the whole health of the person, rather than a single symptom: “It’s really about the provider having that full data around that 1 individual patient…How do you incorporate the data knowing where that patient lives, what their situation is like, and their health condition to know what has worked and what hasn’t worked for that patient."

Building Trust in the Community

According to a recent survey by CHCF, more than 50% of Californians have expressed concern about AI being used in their health care. In response, Dr. Lubarsky emphasized the need for providers to be always transparent and accountable. Further, he believes that organizations who have successfully used AI need to share their results with everyone. “It’s not a competitive advantage to take better care of a patient,” he explained. “It’s a moral imperative.”

Dr. Reyes concluded by highlighting that the importance of every level of the workforce, from clerical workers up to the executive level, to have the cognitive and ethical skills to make judgment calls where AI is concerned—rather than assuming everything an AI tool produces is accurate.

Related Content

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership SummitACCCBuzz Blog

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership Summit

Gabrielle Stearns

April 20, 2026

Bispecific Antibodies Are Moving Forward; So Are the Implementation QuestionsACCCBuzz Blog

Bispecific Antibodies Are Moving Forward; So Are the Implementation Questions

Rifeta Kajdić Hodžić

April 17, 2026

Highlights From Volume 41, Number 2 Oncology IssuesACCCBuzz Blog

Highlights From Volume 41, Number 2 Oncology Issues

Gabrielle Stearns

April 15, 2026

Developing Clinical Insight, Professional Competencies, and Strategic Awareness: NCCN 2026 Annual ConferenceACCCBuzz Blog

Developing Clinical Insight, Professional Competencies, and Strategic Awareness: NCCN 2026 Annual Conference

Rachel Radwan; Gabrielle Stearns

April 8, 2026

Representing Veterans in Clinical Trials Through Public-Private Partnerships: A Q&A With NAVREFACCCBuzz Blog

Representing Veterans in Clinical Trials Through Public-Private Partnerships: A Q&A With NAVREF

Gabrielle Stearns

March 26, 2026

Confronting a Lethal Cancer: Duke Launches Multidisciplinary Pancreatic Cancer Center for Earlier Detection and Better OutcomesACCCBuzz Blog

Confronting a Lethal Cancer: Duke Launches Multidisciplinary Pancreatic Cancer Center for Earlier Detection and Better Outcomes

Rachel Radwan

March 25, 2026

From Hospital to Home: A Solution for Proactive Symptom Monitoring and Precise Care ACCCBuzz Blog

From Hospital to Home: A Solution for Proactive Symptom Monitoring and Precise Care

Rachel Radwan

March 23, 2026

A Candid Conversation About the Power of Early Palliative CareACCCBuzz Blog

A Candid Conversation About the Power of Early Palliative Care

Monique J. Marino

March 19, 2026

Upcoming Events

ACCC Oncology Reimbursement Meeting | Charleston
Oncology

ACCC Oncology Reimbursement Meeting | Charleston

In Person Meeting & NetworkingMay 6, 2026 at 8:00 AM EDT560 King Street, Charleston, SC, USAHyatt Place + Hyatt House Charleston - Historic District, Charleston
Register Now!
ACCC Oncology Reimbursement Meeting | St. Louis
Oncology

ACCC Oncology Reimbursement Meeting | St. Louis

In Person Meeting & NetworkingMay 13, 2026 at 8:00 AM CDT1335 South Lindbergh Boulevard, St. Louis, MO, USAHilton St. Louis Frontenac, St. Louis
Register Now!
ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
IOS 2026 Fellows Dinner Meeting
Oncology

IOS 2026 Fellows Dinner Meeting

In Person Conference & ConventionApril 22, 2026 at 6:00 PM CDT210 S Dubuque St, Iowa City, IA 52240, USAGraduate by Hilton Iowa City, Iowa City
Register Now!
Precision in Practice: Translating MRD Into Oncology Care
Oncology

Precision in Practice: Translating MRD Into Oncology Care

In Person Conference & ConventionApril 28, 2026 at 5:30 PM EDT1020 South Calhoun Street, Fort Wayne, IN, USAHilton Fort Wayne at the Grand Wayne Center, Fort Wayne
Register Now!
MOS 2026 Spring Conference
Oncology

MOS 2026 Spring Conference

In Person Conference & ConventionApril 28, 2026 at 5:15 PM CDT1111 East Broadway, Columbia, MO, USAThe Broadway Columbia (A DoubleTree by Hilton), Columbia
Register Now!
RIOS 2026 Spring Symposium
Oncology

RIOS 2026 Spring Symposium

In Person Conference & ConventionMay 9, 2026 at 11:00 AM EDT4 Richmond Square, Providence, RI 02906, USAWaterman Grille, Providence
Register Now!
 HSCO 2026 May Dinner Symposium
Oncology

HSCO 2026 May Dinner Symposium

In Person Conference & ConventionMay 13, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
WSOS 2026 Laramie Meeting
Oncology

WSOS 2026 Laramie Meeting

In Person Conference & ConventionMay 20, 2026 at 5:30 PM MDT222 South 22nd Street, Laramie, WY, USAUniversity of Wyoming – Rochelle Gateway Center, Laramie
Register Now!
WAHO 2026 Welcome Reception
Oncology

WAHO 2026 Welcome Reception

In Person Conference & ConventionMay 30, 2026 at 5:30 PM CDT1060 W Addison St, Chicago, IL, USAWrigley Field , Chicago
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership Summit

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership Summit

On Friday, April 17, ACCC welcomed oncology leaders from around the country to Washington, DC for the inaugural ACCC Leadership Summit, a forum designed for executive-level decision-makers to engage in strategic dialogue, peer-to-peer exchange, and actionable insights at the highest level of oncology leadership.

Bispecific Antibodies Are Moving Forward; So Are the Implementation Questions

Bispecific Antibodies Are Moving Forward; So Are the Implementation Questions

During the HOPA 2026 annual conference, ACCC brought together a small group of oncology pharmacists for a practical, candid conversation about challenges with the implementation of bispecific antibodies that was deeply grounded in real-world experience and what it takes to operationalize care.

Highlights From Volume 41, Number 2 Oncology Issues

Highlights From Volume 41, Number 2 Oncology Issues

From Ghana to Orlando, experts across the multidisciplinary care team share how they are expanding access to clinical trials and supportive care services and improving quality of life for their patients as a result in this Oncology Issues. Read on for a preview of this issue’s articles and dive deeper to learn from colleagues across the country and the globe.

Developing Clinical Insight, Professional Competencies, and Strategic Awareness: NCCN 2026 Annual Conference

Developing Clinical Insight, Professional Competencies, and Strategic Awareness: NCCN 2026 Annual Conference

On day 1 of the NCCN 2026 Annual Conference, attendees heard from experts on the unique issues young adults with cancer face during and post-treatment, advances in treating gastrointestinal cancers, evolving therapies in skin cancers, and novel approaches to treating blood cancers.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Innovation in Action: Breaking Down the 2025 ACCC Impact Report – [Mini Podcast] Ep. 228

Transforming Palliative Care in Oncology – [Video Podcast] Ep. 227

Streamlining Access to TIL Cell Therapy for Melanoma – [Podcast] Ep. 226

Policy in Practice: Change Hits the Clinic – [Podcast] Ep. 225

View All Podcasts

Latest from Oncology Issues

April 2026
April 2026
February 2026
December 2025
October 2025
August 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login